Theravance Biopharma (TBPH) Asset Writedowns and Impairment (2015 - 2024)
Theravance Biopharma (TBPH) reported Asset Writedowns and Impairment of -$13000.0 for Q4 2024, down 100.83% quarter-over-quarter from $1.6 million in Q3 2024.
Theravance Biopharma (TBPH) Asset Writedowns and Impairment (2015 - 2024) Analysis & Trends
Theravance Biopharma (TBPH) has 4 years of Asset Writedowns and Impairment data on file, last reported at -$13000.0 in Q4 2024.
- Asset Writedowns and Impairment for Q4 2024 came in at -$13000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $9.6 million (changed N/A YoY), and the FY2024 annual result was $4.5 million, changed N/A from the prior year.
- Asset Writedowns and Impairment eased to -$13000.0 in Q4 2024 per TBPH's latest filing, from $1.6 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.6 million in Q3 2024 and troughed at -$13000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Theravance Biopharma | 846.10 Mn | 451.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Dec 31, 2017 | 97,000.00 |
| Dec 31, 2017 | 97,000.00 |
| Sep 30, 2017 | 8.00 Mn |
| Sep 30, 2017 | 8.00 Mn |
| Jun 30, 2017 | 642,000.00 |
| Jun 30, 2017 | 642,000.00 |
| Dec 31, 2016 | 303,000.00 |
| Dec 31, 2016 | 303,000.00 |
| Jun 30, 2016 | 109,000.00 |
| Jun 30, 2016 | 109,000.00 |
| Mar 31, 2016 | 10,000.00 |
| Mar 31, 2016 | 10,000.00 |
| Dec 31, 2015 | -79,000.00 |
| Dec 31, 2015 | -79,000.00 |
| Mar 31, 2015 | 79,000.00 |
| Mar 31, 2015 | 79,000.00 |